72.11.Z - Research and experimental development on biotechnology
10.91.Z - Manufacture of prepared feeds for farm animals
20.14.Z - Manufacture of other organic basic chemicals
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
26.51.Z - Manufacture of instruments and appliances for measuring, testing and navigation
62.01.Z - Computer programming activities
62.09.Z - Other information technology and computer service activities
72.19.Z - Other research and experimental development on natural sciences and engineering
85.59.B - Other out-of-school forms of education, not elsewhere classified
2020 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -3,2 | -3,3 | -3,4 | -5,3 |
Gross profit (loss) | -3,6 | -3,8 | -4,4 | -16,6 |
EBITDA | -3,2 | -3,3 | -3,4 | -5,3 |
Short time liabilities | 0 | 10,8 | 11,6 | 7,3 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | -3,5 | 0 | -4,4 | -19 752,7 |
Operating profit (EBIT) | -3,2 | -3,3 | -3,4 | -5,3 |
Assets | 7 | 10,8 | 7,2 | -33,2 |
Net profit (loss) | -3,6 | -3,8 | -4,4 | -16,6 |
Cash | 2,8 | 5,8 | 1,7 | -70,9 |
Liabilities and provisions for liabilities | 10,6 | 10,8 | 11,6 | 7,3 |
Net income from sale | 0 | 0 | 0 | 0 |
Working assets | 7 | 10,8 | 7,2 | -33,2 |
Other income costs | 0 | 0 | 0 | -8,3 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 102,3 | -16 925,3 | 100,5 | 17 025,8 |
Equity capital to total assets | -50,3 | 0,2 | -60,4 | -60,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 1.002058982849121 | 0.62343829870224 | -0,4 | |
Net dept to EBITDA | -2.4045584201812744 | -1.4626494646072388 | -2.8549187183380127 | -1,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane